GENEVA, Oct. 30 -- COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH filed a patent application (IN2026/050717) for “RECOMBINANT mRNA VACCINE AGAINST SARS-COV-2”. With publication no. WO/2026/224730, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/215
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....